CK-0045 Proof-of-concept Study in Participants With Overweight / Obesity and Type 2 Diabetes

Clinical trial NCT06611930 · TERMINATED

Trial details

NCT number: NCT06611930
Sponsor: Cytoki Pharma
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Type 2 Diabetes Mellitus (T2DM)Obesity and Overweight

Start date: 2024-09-06
Primary completion: 2025-09-06
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.